Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients With mCRPC Treated With Abiraterone

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients With mCRPC Treated With Abiraterone

Background: A systemic immune-inflammation index (SII) based on neutrophil (N), lymphocyte (L), and platelet (P) counts has shown a prognostic impact in several solid tumors. The aim of this study is to evaluate the prognostic role of SII in mCRPC patients treated with abiraterone post docetaxel.Pat...

Full description

Bibliographic Details
Main Authors: Cristian Lolli, Orazio Caffo, Emanuela Scarpi, Michele Aieta, Vincenza Conteduca, Francesca Maines, Emanuela Bianchi, Francesco Massari, Antonello Veccia, Vincenzo E. Chiuri, Gaetano Facchini, Ugo De Giorgi
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-10-01
Series:Frontiers in Pharmacology
Subjects:
PSA
prostate cancer
abiraterone
crpc
Prognostic factor
systemic immune inflammation index
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00376/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00376/full

Similar Items